Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1802 1
1811 1
1822 2
1848 1
1852 1
1869 1
1874 2
1875 1
1880 1
1885 1
1887 3
1888 2
1891 2
1893 1
1894 1
1895 1
1896 1
1899 2
1900 1
1901 2
1902 1
1903 1
1904 2
1906 1
1907 1
1909 2
1914 1
1915 3
1916 4
1917 4
1918 5
1919 7
1920 1
1921 1
1922 1
1923 1
1925 1
1926 3
1927 2
1928 2
1929 4
1930 2
1931 4
1932 5
1933 4
1934 1
1935 3
1936 2
1937 2
1938 3
1940 1
1942 3
1944 2
1945 50
1946 206
1947 191
1948 186
1949 180
1950 134
1951 297
1952 481
1953 500
1954 504
1955 457
1956 382
1957 419
1958 419
1959 168
1960 42
1961 34
1962 55
1963 342
1964 534
1965 1160
1966 2315
1967 3945
1968 5717
1969 7430
1970 8515
1971 9810
1972 11473
1973 12796
1974 13724
1975 11504
1976 10111
1977 11252
1978 11945
1979 12985
1980 11834
1981 11767
1982 14030
1983 16668
1984 15642
1985 16212
1986 16759
1987 17975
1988 20535
1989 22946
1990 24896
1991 24739
1992 24887
1993 24698
1994 26012
1995 26678
1996 26931
1997 28295
1998 29123
1999 28564
2000 31699
2001 33605
2002 36514
2003 40466
2004 43203
2005 46336
2006 49140
2007 50665
2008 53993
2009 56654
2010 60233
2011 65787
2012 69952
2013 72187
2014 72874
2015 75680
2016 73889
2017 74258
2018 73112
2019 73880
2020 68069
2021 52450
2022 24876
2023 21907
2024 9781

Text availability

Article attribute

Article type

Publication date

Search Results

1,747,470 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ad in
Your search for adzin retrieved no results
Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression.
Katz EG, Hough D, Doherty T, Lane R, Singh J, Levitan B. Katz EG, et al. Clin Pharmacol Ther. 2021 Feb;109(2):536-546. doi: 10.1002/cpt.2024. Epub 2020 Oct 13. Clin Pharmacol Ther. 2021. PMID: 32860422 Free PMC article. Clinical Trial.
Risks were death, suicidal ideation, most common adverse events (AEs), and potential long-term risks. Per 100 patients on esketamine + AD vs. AD + placebo in induction therapy, 5-21 additional patients would remit and 14-17 additional patients would respond. ...Thes …
Risks were death, suicidal ideation, most common adverse events (AEs), and potential long-term risks. Per 100 patients on esketamine + AD …
Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies.
Mandlik DS, Mandlik SK. Mandlik DS, et al. Immunopharmacol Immunotoxicol. 2021 Apr;43(2):105-125. doi: 10.1080/08923973.2021.1889583. Epub 2021 Feb 28. Immunopharmacol Immunotoxicol. 2021. PMID: 33645388 Review.
The attributes of AD include dry skin, pruritus, lichenification and frequent eczematous abrasions. ...Instead of the severe side effects of topical steroids and oral antihistamines, herbal plants and their derived phytoconstituents are commonly used for the treatment of …
The attributes of AD include dry skin, pruritus, lichenification and frequent eczematous abrasions. ...Instead of the severe side eff …
AD(H)D.
Harrison C, Charles J, Britt H. Harrison C, et al. Aust Fam Physician. 2008 Jun;37(6):393. Aust Fam Physician. 2008. PMID: 18523688 Free article.
The BEACH program (Bettering the Evaluation and Care of Health) shows that management of attention deficit (hyperactivity) disorder (AD(H)D) was rare in general practice, occurring only six times per 1,000 encounters with children aged 5-17 years, between April 2000 and De …
The BEACH program (Bettering the Evaluation and Care of Health) shows that management of attention deficit (hyperactivity) disorder (AD …
Management of Atopic Dermatitis in Japan.
Saeki H. Saeki H. J Nippon Med Sch. 2017;84(1):2-11. doi: 10.1272/jnms.84.2. J Nippon Med Sch. 2017. PMID: 28331140 Free article. Review.
Based on the definition and diagnostic criteria for AD of the JDA, patients meeting three basic criteria, 1) pruritus, 2) typical morphology and distribution of the eczema, and 3) chronic or chronically relapsing course, are regarded as having AD. ...Drugs that pote …
Based on the definition and diagnostic criteria for AD of the JDA, patients meeting three basic criteria, 1) pruritus, 2) typical mor …
Pharmacological management of atopic dermatitis in the elderly.
Howell AN, Ghamrawi RI, Strowd LC, Feldman SR. Howell AN, et al. Expert Opin Pharmacother. 2020 May;21(7):761-771. doi: 10.1080/14656566.2020.1729738. Epub 2020 Feb 26. Expert Opin Pharmacother. 2020. PMID: 32100586 Review.
INTRODUCTION: The prevalence of atopic dermatitis (AD) in geriatric populations of industrialized countries is currently estimated at 3-4% and continues to increase. AD is associated with significant morbidity, increased susceptibility to infection, and symptoms of …
INTRODUCTION: The prevalence of atopic dermatitis (AD) in geriatric populations of industrialized countries is currently estimated at …
Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond.
Koola MM. Koola MM. Psychiatry Res. 2020 Nov;293:113409. doi: 10.1016/j.psychres.2020.113409. Epub 2020 Aug 18. Psychiatry Res. 2020. PMID: 32829072 Review.
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly population worldwide. ...Both galantamine and memantine are FDA-approved medications for the treatment of AD. The objective of this review is to highlight the potential of the galantamine …
Alzheimer's disease (AD) is the most prevalent form of dementia in the elderly population worldwide. ...Both galantamine and memantin …
Novel topical and systemic therapies in atopic dermatitis.
Suga H, Sato S. Suga H, et al. Immunol Med. 2019 Jun;42(2):84-93. doi: 10.1080/25785826.2019.1642727. Epub 2019 Jul 18. Immunol Med. 2019. PMID: 31318324 Review.
It is well known that dupilumab, which blocks receptor binding of both IL-4 and IL-13, is remarkably efficacious in the treatment of AD. We have entered a new era when many novel topical and systemic agents that may have great potential in AD treatment are emerging …
It is well known that dupilumab, which blocks receptor binding of both IL-4 and IL-13, is remarkably efficacious in the treatment of AD …
Adjunctive Management of Itch in Atopic Dermatitis.
Elmariah SB. Elmariah SB. Dermatol Clin. 2017 Jul;35(3):373-394. doi: 10.1016/j.det.2017.02.011. Epub 2017 May 6. Dermatol Clin. 2017. PMID: 28577806 Review.
Itch, or pruritus, is a hallmark feature of atopic dermatitis (AD). The impact of AD-related pruritus can range from mildly distressing or distracting to completely disabling. Traditionally, management of itch in AD patients has focused on restoring the alter …
Itch, or pruritus, is a hallmark feature of atopic dermatitis (AD). The impact of AD-related pruritus can range from mildly di …
Topical micronutrients in atopic dermatitis-An evidence-based review.
Maarouf M, Vaughn AR, Shi VY. Maarouf M, et al. Dermatol Ther. 2018 Sep;31(5):e12659. doi: 10.1111/dth.12659. Epub 2018 Jul 17. Dermatol Ther. 2018. PMID: 30019437 Review.
The role of dietary factors is an important and controversial topic in the pathogenesis of atopic dermatitis (AD). Despite the preponderance of consumer products utilizing oral micronutrients supplementation for relief AD symptoms, less attention has been paid on th …
The role of dietary factors is an important and controversial topic in the pathogenesis of atopic dermatitis (AD). Despite the prepon …
Therapeutic benefits of H₂S in Alzheimer's disease.
Wei HJ, Li X, Tang XQ. Wei HJ, et al. J Clin Neurosci. 2014 Oct;21(10):1665-9. doi: 10.1016/j.jocn.2014.01.006. Epub 2014 Jun 2. J Clin Neurosci. 2014. PMID: 24882562 Review.
The aim of this review is to present the current understanding of H2S as a potential agent for the treatment of Alzheimer's disease (AD). Dysregulation of H2S homeostasis is implicated in the pathological processes of AD. ...We conclude that H2S has potential therap …
The aim of this review is to present the current understanding of H2S as a potential agent for the treatment of Alzheimer's disease (AD …
1,747,470 results
You have reached the last available page of results. Please see the User Guide for more information.